Furthermore, patients with high NUSAP1 expression in ACC, KICH, KIRP, LGG, PAAD, and PARD had a higher risk of recurrence compared to those with low NUSAP1 levels (Figure 4C and Supplementary Table S3). Here, NUSAP1 is linked to pancreatic adenocarcinoma.